{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:16:49Z","timestamp":1790741809583,"version":"4.1.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:00:00Z","timestamp":1761177600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004440","name":"Wellcome","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015542","name":"GlaxoSmithKline Japan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006190","name":"Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006190","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001322","name":"South African Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011723","name":"Canton de Gen\u00e8ve","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011723","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004423","name":"World Health Organization","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004423","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Federal Ministry of Education and Research Bonn Office","doi-asserted-by":"publisher","award":["01KA2115"],"award-info":[{"award-number":["01KA2115"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Federal Ministry of Education and Research Bonn Office","doi-asserted-by":"publisher","award":["01KA2411"],"award-info":[{"award-number":["01KA2411"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Microbe"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.lanmic.2025.101288","type":"journal-article","created":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T20:04:07Z","timestamp":1767989047000},"page":"101288","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["An overview of global public and philanthropic investments into antibacterial therapeutics (2017\u201323)"],"prefix":"10.1016","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8263-0190","authenticated-orcid":false,"given":"Lloyd","family":"Czaplewski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-0602-4887","authenticated-orcid":false,"given":"Usha","family":"Lamichhane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Sudbrak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Hennessy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9794-2915","authenticated-orcid":false,"given":"Lesley A","family":"Ogilvie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura JV","family":"Piddock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lanmic.2025.101288_bib1","first-page":"383","article-title":"Antimicrobial resistance","volume":"61","year":"1983","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.lanmic.2025.101288_bib2","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/S0140-6736(24)01867-1","article-title":"Global burden of bacterial antimicrobial resistance 1990\u20132021: a systematic analysis with forecasts to 2050","volume":"404","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.lanmic.2025.101288_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2021.106103","article-title":"Antimicrobial resistance: prevalence, economic burden, mechanisms of resistance and strategies to overcome","volume":"170","author":"Pulingam","year":"2022","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.lanmic.2025.101288_bib4","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/nrd.2016.155","article-title":"Accelerating global innovation to address antibacterial resistance: introducing CARB-X","volume":"15","author":"Outterson","year":"2016","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.lanmic.2025.101288_bib5","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/d41573-021-00074-y","article-title":"ENABLE: an engine for European antibacterial drug discovery and development","volume":"20","author":"Olliver","year":"2021","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.lanmic.2025.101288_bib6","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1021\/acsinfecdis.0c00101","article-title":"The Global Antibiotic Research and Development Partnership (GARDP) not-for-profit model of antibiotic development","volume":"6","author":"Balasegaram","year":"2020","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.lanmic.2025.101288_bib9","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S1473-3099(17)30753-3","article-title":"Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis","volume":"18","author":"Tacconelli","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.lanmic.2025.101288_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.lanmic.2024.07.003","article-title":"WHO publishes updated list of bacterial priority pathogens","volume":"5","author":"Jesudason","year":"2024","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.lanmic.2025.101288_bib11","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00535-24","article-title":"Multi-year analysis of the global preclinical antibacterial pipeline: trends and gaps","volume":"68","author":"Gigante","year":"2024","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.lanmic.2025.101288_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.lanmic.2024.100992","article-title":"Addressing urgent priorities in antibiotic development: insights from WHO 2023 antibacterial clinical pipeline analyses","volume":"6","author":"Melchiorri","year":"2025","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.lanmic.2025.101288_bib13","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/s41570-021-00313-1","article-title":"Towards the sustainable discovery and development of new antibiotics","volume":"5","author":"Miethke","year":"2021","journal-title":"Nat Rev Chem"},{"key":"10.1016\/j.lanmic.2025.101288_bib14","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1038\/s41591-024-03218-w","article-title":"Advancing global antibiotic research, development and access","volume":"30","author":"Piddock","year":"2024","journal-title":"Nat Med"},{"key":"10.1016\/j.lanmic.2025.101288_bib15","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1021\/acsinfecdis.4c00530","article-title":"Challenges and opportunities with antibiotic discovery and exploratory research","volume":"10","author":"Piddock","year":"2024","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.lanmic.2025.101288_bib16","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1057\/s41599-024-03452-0","article-title":"Novel insights from financial analysis of the failure to commercialise plazomicin: implications for the antibiotic investment ecosystem","volume":"11","author":"Wells","year":"2024","journal-title":"Humanit Soc Sci Commun"},{"key":"10.1016\/j.lanmic.2025.101288_bib17","article-title":"Challenges and opportunities for incentivising antibiotic research and development in Europe","volume":"33","author":"Anderson","year":"2023","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.lanmic.2025.101288_bib19","article-title":"UK launches subscription style model for antibiotics to encourage new development","volume":"369","author":"Mahase","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.lanmic.2025.101288_bib22","doi-asserted-by":"crossref","first-page":"e4451","DOI":"10.1093\/cid\/ciaa852","article-title":"Antibacterial R&D at a crossroads: we\u2019ve pushed as hard as we can \u2026 now we need to start pulling!","volume":"73","author":"Rex","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.lanmic.2025.101288_bib24","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1021\/acsinfecdis.0c00069","article-title":"Fostering antibiotic development through impact funding","volume":"6","author":"Engel","year":"2020","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.lanmic.2025.101288_bib26","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s40545-018-0135-0","article-title":"Insights into early stage of antibiotic development in small- and medium-sized enterprises: a survey of targets, costs, and durations","volume":"11","author":"\u00c5rdal","year":"2018","journal-title":"J Pharm Policy Pract"},{"key":"10.1016\/j.lanmic.2025.101288_bib28","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3390\/v10020064","article-title":"The magistral phage","volume":"10","author":"Pirnay","year":"2018","journal-title":"Viruses"},{"key":"10.1016\/j.lanmic.2025.101288_bib29","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S1473-3099(15)00466-1","article-title":"Alternatives to antibiotics-a pipeline portfolio review","volume":"16","author":"Czaplewski","year":"2016","journal-title":"Lancet Infect Dis"}],"container-title":["The Lancet Microbe"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666524725002162?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666524725002162?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T01:52:57Z","timestamp":1774057977000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666524725002162"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S2666524725002162"],"URL":"https:\/\/doi.org\/10.1016\/j.lanmic.2025.101288","relation":{},"ISSN":["2666-5247"],"issn-type":[{"value":"2666-5247","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An overview of global public and philanthropic investments into antibacterial therapeutics (2017\u201323)","name":"articletitle","label":"Article Title"},{"value":"The Lancet Microbe","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lanmic.2025.101288","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101288"}}